Article
San Francisco - Two large phase III studies involving 15 percent azelaic gel (Finacea) for the treatment of rosacea each resulted in more than a 50-percent reduction in the number of lesions.
Challenges and Future Directions in Microbiome Engineering
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
Optimizing Vitiligo Care: Key Expert Takeaways
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Daily Derm Times: March 31, 2025
Patients with Vitiligo Have a Lower Risk of Developing Serious Infections, New Poster Finds